| Literature DB >> 28445381 |
J Peter Rubin1,2, Richard A D'Amico1,2, Ricardo Rodriguez1,2, Sydney R Coleman1,2, Paul Cederna1,2, Scot Glasberg1,2, Michael Neumeister1,2, David H Song1,2, Charles Butler1,2, Keith M Hume1,2.
Abstract
The U.S. Food and Drug Administration released draft guidance documents on human cells, tissues, and cellular and tissue-based products regulations. These proposed guidance documents can impact the practice of plastic surgery in the area of tissue grafting procedures. This article describes the relevant issues in these draft guidance documents, and presents the comments provided to the U.S. Food and Drug Administration by the American Society of Plastic Surgeons.Entities:
Mesh:
Year: 2017 PMID: 28445381 DOI: 10.1097/PRS.0000000000003240
Source DB: PubMed Journal: Plast Reconstr Surg ISSN: 0032-1052 Impact factor: 4.730